Furoin, a benzoin analogue, was examined as novel fluorogenic reagent for the selective and sensitive LC determination of various guanidines after pre-column derivatization. The derivatization reaction was carried out at 100°C for 5 min to give adducts that were separated on a Phenomenex Synergi MAX-RP column. The reagent showed to be useful both for determining together arginine (Arg) and creatine (CT) in dietary supplements under elution isocratic conditions and for the simultaneous analysis of a variety of guanidines in biological samples (human plasma and urine) under elution gradient conditions. The detection limits ranged from 7 to 25 fmol. Recovery studies showed good results for all determined guanidino compounds (85.6%-106.2%; R.S.D.= 1.1-6.2%).

Liquid chromatographic analysis of guanidino compounds using furoin as a new fluorogenic reagent / R.Gatti*; M.G.Gioia. - In: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. - ISSN 0731-7085. - STAMPA. - 48:(2008), pp. 754-759. [10.1016/j.jpba.2008.07.017]

Liquid chromatographic analysis of guanidino compounds using furoin as a new fluorogenic reagent

GATTI, RITA;GIOIA, MARIA GRAZIA
2008

Abstract

Furoin, a benzoin analogue, was examined as novel fluorogenic reagent for the selective and sensitive LC determination of various guanidines after pre-column derivatization. The derivatization reaction was carried out at 100°C for 5 min to give adducts that were separated on a Phenomenex Synergi MAX-RP column. The reagent showed to be useful both for determining together arginine (Arg) and creatine (CT) in dietary supplements under elution isocratic conditions and for the simultaneous analysis of a variety of guanidines in biological samples (human plasma and urine) under elution gradient conditions. The detection limits ranged from 7 to 25 fmol. Recovery studies showed good results for all determined guanidino compounds (85.6%-106.2%; R.S.D.= 1.1-6.2%).
2008
Liquid chromatographic analysis of guanidino compounds using furoin as a new fluorogenic reagent / R.Gatti*; M.G.Gioia. - In: JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS. - ISSN 0731-7085. - STAMPA. - 48:(2008), pp. 754-759. [10.1016/j.jpba.2008.07.017]
R.Gatti*; M.G.Gioia
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/63115
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 14
social impact